Development of local guidelines for prevention of respiratory syncytial viral infections

Pediatr Infect Dis J. 1999 Oct;18(10):850-3. doi: 10.1097/00006454-199910000-00003.
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Decision Making
  • Hospitalization / economics
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunoglobulins, Intravenous / economics
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / economics
  • Infant, Premature, Diseases / prevention & control*
  • Practice Guidelines as Topic
  • Respiratory Syncytial Virus Infections / economics
  • Respiratory Syncytial Virus Infections / prevention & control*
  • Respiratory Syncytial Viruses / immunology*
  • Risk

Substances

  • Immunoglobulins, Intravenous
  • respiratory syncytial virus immune globulin intravenous